Lenampicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H23N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8M568DM08K, chemically known as 2,3-dihydroxy-2-butenyl(2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, cyclic carbonate but generally known as lenampicillin, which bears US NIH Compound Identifier 65646. European Medicines Agency schedules Lenampicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08430MIG. The term LENAMPICILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). LENAMPICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lenampicillin under HS 29411090 and SITC 54131. As of Q4 2014, LENAMPICILLIN remains the US FDA Preferred Term for this commodity. Lenampicillin bears US NLM identifiers UMLS ID C0125457 and NCI Concept Code C90912. SMILES: S1C2N(C(C1(C)C)C(=O)OCC1OC(=O)OC1C)C(=O)C2NC(=O)C(N)C1CCCCC1.